The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release
Open accessAbstract
Prostaglandins (PGs) are important lipid mediators involved in the development of inflammatory associated pain and fever. PGE2 is a well‐established endogenous pyrogen activated by proinflammatory cytokine interleukin (IL)‐1β. P2X7 receptors (P2X7Rs) expressed by inflammatory cells are stimulated by the danger signal extracellular ATP to activate the inflammasome and release IL‐1β. Here we show that P2X7R activation is required for the release of PGE2 and other autacoids independent of inflammasome activation, with an ATP EC 50 for PGE2 and IL‐1β release of 1.58 and 1.23 mM, respectively. Furthermore, lack of P2X7R or specific antagonism of P2X7R decreased the febrile response in mice triggered after intraperitoneal LPS or IL‐1β inoculation. Accordingly, LPS inoculation caused intraperitoneal ATP accumulation. Therefore, P2X7R antagonists emerge as novel therapeutics for the treatment for acute inflammation, pain and fever, with wider anti‐inflammatory activity than currently used cyclooxygenase inhibitors.—Barberà‐Cremades, M., Baroja‐Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., Pelegrín, P. P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release. FASEB J. 26, 2951–2962 (2012). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, in a disease state as infection or brain disease, extracellular ATP levels largely increase and activate P2X7 receptors [68–70].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [70]
In the citing paper
“In fact, the role of P2X7 receptor as a modulator of inflammatory response is well-established [16, 70].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [70]
Citations
Cites
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J. M., Perregaux, D. G., Stam, E. J., Petrushova, N., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 924
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J. C., Peck, W. L., et al. (2005) · Pain · doi:10.1016/j.pain.2005.01.002 · Cited by 807
Netea, M. G., Nold‐Petry, C. A., Nold, M. F., Joosten, L. A. B., Opitz, B., van der Meer, J. H. M., van de Veerdonk, F. L., Ferwerda, G., Heinhuis, B., Devesa, I., et al. (2008) · Blood · doi:10.1182/blood-2008-03-146720 · Cited by 787
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., & Di Virgilio, F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002599 · Cited by 668
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells
Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Willart, M. A. M., Muskens, F., Hoogsteden, H. C., Luttmann, W., Ferrari, D., Virgilio, F. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1617 · Cited by 620
Ulmann, L., Hatcher, J. P., Hughes, J. P., Chaumont‐Dubel, S., Green, P. J., Conquet, F., Buell, G. N., Reeve, A. J., Chessell, I. P., & Rassendren, F. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2308-08.2008 · Cited by 572
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes
von Kügelgen, I. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.014 · Cited by 549
Cited by
Sorted by citations
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267
Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 936
Extracellular purines, purinergic receptors and tumor growth
Virgilio, F. D., & Adinolfi, E. (2016) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 567
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 409
P2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390
The P2X7 receptor: A main player in inflammation
Adinolfi, E., Giuliani, A. L., De Marchi, E., Pegoraro, A., Orioli, E., & Di Virgilio, F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.021 · Cited by 385
Purine Release, Metabolism, and Signaling in the Inflammatory Response
Linden, J. M., Koch‐Nolte, F., & Dahl, G. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052406 · Cited by 389
Calcium-Permeable Ion Channels in Pain Signaling
Bourinet, E., Altier, C., Hildebrand, M. E., Trang, T., Salter, M. W., & Zamponi, G. W. (2014) · Physiological Reviews · doi:10.1152/physrev.00023.2013 · Cited by 349
Inflammasome-dependent IL-1β release depends upon membrane permeabilisation
Martín‐Sánchez, F., Diamond, C. E., Zeitler, M., Gomez, A. I., Baroja‐Mazo, A., Bagnall, J., Spiller, D. G., White, M. H., Daniels, M. J. D., Mortellaro, A., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2015.176 · Cited by 293
Self-citationBooshehri, L. M., & Hoffman, H. M. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00638-z · Cited by 253
P2X7 receptor and the NLRP3 inflammasome: Partners in crime
Pelegrín, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114385 · Cited by 253
Self-citationThe NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases
de Torre‐Minguela, C., Mesa-del-Castillo, P., & Pelegrín, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00043 · Cited by 251
Self-citationSluyter, R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2017_59 · Cited by 235
Jacob, F., Perez-Novo, C. A., Bachert, C., & Crombruggen, K. V. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9357-4 · Cited by 239
Purinergic signaling in the immune system
Virgilio, F. D., & Vuerich, M. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.04.011 · Cited by 238
P2X ion channel receptors and inflammation
Burnstock, G. (2016) · Purinergic Signalling · doi:10.1007/s11302-015-9493-0 · Cited by 215
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
Adinolfi, E., Capece, M., Franceschini, A., Falzoni, S., Giuliani, A. L., Rotondo, A., Sarti, A. C., Bonora, M., Syberg, S., Corigliano, D. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1259 · Cited by 177
Sokołowska, M., Chen, L., Liu, Y., Martínez‐Antón, A., Qi, H., Logun, C., Alsaaty, S., Park, Y. H., Kastner, D. L., Chae, J. J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401343 · Cited by 177
P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Lara, R., Adinolfi, E., Harwood, C. A., Philpott, M. P., Barden, J. A., Virgilio, F. D., & McNulty, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00793 · Cited by 174
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145
Detecting adenosine triphosphate in the pericellular space
Falzoni, S., Donvito, G., & Di Virgilio, F. (2013) · Interface Focus · doi:10.1098/rsfs.2012.0101 · Cited by 136
Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors
Jelassi, B., Anchelin, M., Chamouton, J., Cayuela, M. L., Clarysse, L., Li, J., Goré, J., Jiang, L., & Roger, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt099 · Cited by 146
Gasdermins mediate cellular release of mitochondrial DNA during pyroptosis and apoptosis
de Torre‐Minguela, C., Gómez, A. I., Couillin, I., & Pelegrı́n, P. (2021) · The FASEB Journal · doi:10.1096/fj.202100085r · Cited by 140
Self-citationde Torre‐Minguela, C., Barberà-Cremades, M., Gómez, A. I., Martín‐Sánchez, F., & Pelegrı́n, P. (2016) · Scientific Reports · doi:10.1038/srep22586 · Cited by 135
Self-citationCsölle, C., Baranyi, M., Zsilla, G., Kittel, Á., Gölöncsér, F., Illes, P., Papp, E., Vizi, E. S., & Sperlágh, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066547 · Cited by 128
Fiebich, B. L., Akter, S., & Akundi, R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00260 · Cited by 130
Autocrine Regulation of Macrophage Activation via Exocytosis of ATP and Activation of P2Y11 Receptor
Sakaki, H., Tsukimoto, M., Harada, H., Moriyama, Y., & Kojima, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059778 · Cited by 122
Gong, D., Zhang, J., Chen, Y., Xu, Y., Ma, J., Hu, G., Yi-ran, H., Zheng, J., Zhai, W., & Xue, W. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1223-y · Cited by 113
P2X7 Receptor as a Therapeutic Target
Marchi, E. D., Orioli, E., Ben, D. D., & Adinolfi, E. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.004 · Cited by 117
Killeen, M. E., Ferris, L. K., Kupetsky, E. A., Falo, L. D., & Mathers, A. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202045 · Cited by 111
Extracellular ATP and other nucleotides—ubiquitous triggers of intercellular messenger release
Zimmermann, H. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9483-2 · Cited by 112
Roger, S., Jelassi, B., Couillin, I., Pelegrín, P., Besson, P., & Jiang, L. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.029 · Cited by 103
Self-citationIon homeostasis and ion channels in NLRP3 inflammasome activation and regulation
Hafner‐Bratkovič, I., & Pelegrı́n, P. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.010 · Cited by 96
Self-citationAlves, L. A., Soares‐Bezerra, R. J., Faria, R. X., Ferreira, L., & Frutuoso, V. D. S. (2013) · Molecules · doi:10.3390/molecules180910953 · Cited by 97
Modulation of innate and adaptive immunity by P2X ion channels
Virgilio, F. D., Sarti, A. C., & Grassi, F. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.026 · Cited by 95
Ectonucleotidases in Acute and Chronic Inflammation
Giuliani, A. L., Sarti, A. C., & Virgilio, F. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619458 · Cited by 83
Ursu, D., Ebert, P. J., Langron, E., Ruble, C., Munsie, L. M., Zou, W., Fijal, B. A., Qian, Y., McNearney, T. A., Mogg, A. J., et al. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-37 · Cited by 77
Emerging role of P2X7 receptors in CNS health and disease
Tewari, M., & Seth, P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.10.001 · Cited by 80
Barberà-Cremades, M., Gómez, A. I., Baroja‐Mazo, A., Martínez-Alarcón, L., Martínez, C. M., de Torre‐Minguela, C., & Pelegrı́n, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00862 · Cited by 71
Self-citationToki, Y., Takenouchi, T., Harada, H., Tanuma, S., Kitani, H., Kojima, S., & Tsukimoto, M. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.011 · Cited by 70
Imaging extracellular ATP with a genetically-encoded, ratiometric fluorescent sensor
Conley, J. M., Radhakrishnan, S., Valentino, S. A., & Tantama, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187481 · Cited by 73
Regulation of Hemichannels and Gap Junction Channels by Cytokines in Antigen-Presenting Cells
Sáez, P. J., Shoji, K. F., Aguirre, A., & Sáez, J. C. (2014) · Mediators of Inflammation · doi:10.1155/2014/742734 · Cited by 68
Chaves, M. M., Marques-da-Silva, C., Monteiro, A. P. T., Canetti, C. D. A., & Coutinho‐Silva, R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301058 · Cited by 67
Sathanoori, R., Swärd, K., Olde, B., & Erlinge, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125111 · Cited by 66
Li, J.-M., Deng, H., Yao, Y.-D., Wang, W., Hu, J.-Q., Dong, Y., Wang, P., Liu, L., Liu, Z., Xie, Y., et al. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01124-4 · Cited by 62
Understanding the role of P2X7 in affective disorders—are glial cells the major players?
Stokes, L., Spencer, S. J., & Jenkins, T. A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00258 · Cited by 59
Stockwell, M. S., Broder, K. R., LaRussa, P. S., Lewis, P., Fernandez, N., Sharma, D., Barrett, A. E., Sosa, J., & Vellozzi, C. J. (2014) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.4469 · Cited by 56
Fan, Z., Zhang, Y., Yi-hong, G., Huang, N., Ma, H., Huang, H., & Yu, H. (2016) · Scientific Reports · doi:10.1038/srep35804 · Cited by 56
Zhong, S., Zhou, Z., Liang, Y., Cheng, X., Li, Y., Teng, W., Zhao, M., Liu, C., Guan, M., & Zhao, C. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1608905 · Cited by 56
Mishra, A., Behura, A., Kumar, A., Naik, L., Swain, A., Das, M., Sarangi, S. S., Dokania, P., Dirisala, V. R., Bhutia, S. K., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174235 · Cited by 53
Huang, T., Lai, H., Chen, Y.-B., Chen, L.-G., Wu, Y., Ko, Y., Lu, C., Chang, C., Wu, C.-Y., Martel, J., et al. (2013) · Innate Immunity · doi:10.1177/1753425913507096 · Cited by 53
ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis
da Silva, J. L. G., Passos, D. F., Bernardes, V. M., & Leal, D. B. R. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.08.009 · Cited by 51
Gonzaga, D. T. G., Ferreira, L. B. G., Costa, T. E. M. M., von Ranke, N. L., Pacheco, P. A. F., Simões, A., Arruda, J. C., Dantas, L. P., Freitas, H. R., Reis, R. A. D. M., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.034 · Cited by 49
Genetic variation in P2RX7 and pain tolerance
Kambur, O., Kaunisto, M. A., Winsvold, B. S., Wilsgaard, T., Stubhaug, A., Zwart, J., Kalso, E. A., & Nielsen, C. S. (2018) · Pain · doi:10.1097/j.pain.0000000000001188 · Cited by 49
CD14 release induced by P2X7 receptor restricts inflammation and increases survival during sepsis
Alarcón‐Vila, C., Baroja‐Mazo, A., de Torre‐Minguela, C., Martínez, C. M., Martínez-García, J. J., Martínez‐Banaclocha, H., García-Palenciano, C., & Pelegrı́n, P. (2020) · eLife · doi:10.7554/elife.60849 · Cited by 48
Self-citationNovel biologics targeting the P2X7 ion channel
Koch‐Nolte, F., Eichhoff, A. M., Pinto-Espinoza, C., Schwarz, N., Schäfer, T., Menzel, S., Haag, F., Demeules, M., Gondé, H., & Adriouch, S. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.03.001 · Cited by 51
P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophages
Bockstiegel, J., Engelhardt, J., & Weindl, G. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01356-1 · Cited by 48
Chen, J., Zhao, Y., & Liu, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00656 · Cited by 45
Inflammasome Activation Induced by a Snake Venom Lys49-Phospholipase A2 Homologue
Boeno, C. N., Paloschi, M. V., Lopes, J. A., Pires, W. L., Setúbal, S. D. S., Evangelista, J. R., Soares, A. M., & Zuliani, J. P. (2019) · Toxins · doi:10.3390/toxins12010022 · Cited by 42
The P2X7 Receptor in Osteoarthritis
Li, Z., Huang, Z., & Bai, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.628330 · Cited by 42
P2X7 Receptor Function in Bone-Related Cancer
Adinolfi, E., Amoroso, F., & Giuliani, A. L. (2012) · Journal of Osteoporosis · doi:10.1155/2012/637863 · Cited by 42
Tajbakhsh, A., Pasdar, A., Rezaee, M., Fazeli, M., Soleimanpour, S., Hassanian, S. M., FarshchiyanYazdi, Z., Rad, T. Y., Ferns, G. A., & Avan, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26277 · Cited by 40
P2X7 receptor in cardiovascular disease: The heart side
Martinez, C. G. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13079 · Cited by 41
Schachter, J., Guijarro, A., Angosto-Bazarra, D., Pinilla, M., Hurtado‐Navarro, L., Meunier, É., Pérez‐Oliva, A. B., Schwarzbaum, P. J., & Pelegrín, P. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115233 · Cited by 42
Self-citationGarré, J. M., Silva, H. M., Lafaille, J. J., & Yang, G. (2020) · Nature Communications · doi:10.1038/s41467-020-15590-5 · Cited by 39
Baroja‐Mazo, A., & Pelegrı́n, P. (2012) · Journal of Osteoporosis · doi:10.1155/2012/408242 · Cited by 38
Self-citationD’Alimonte, I., Nargi, E., Zuccarini, M., Lanuti, P., Iorio, P. D., Giuliani, P., Ricci‐Vitiani, L., Pallini, R., Caciagli, F., & Ciccarelli, R. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9454-7 · Cited by 37
Shimada, H., Nakamura, Y., Nakanishi, T., & Tamai, I. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.10.009 · Cited by 36
Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury
Nadal-Nicolás, F. M., Galindo‐Romero, C., Valiente‐Soriano, F. J., Barberà-Cremades, M., de Torre‐Minguela, C., Salinas‐Navarro, M., Pelegrı́n, P., & Agudo‐Barriuso, M. (2016) · Scientific Reports · doi:10.1038/srep38499 · Cited by 35
Self-citationThe role of microglia and P2X7 receptors in gliomas
Kan, L. K., Williams, D. J., Drummond, K. J., O'Brien, T. J., & Monif, M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.04.010 · Cited by 37
Calzaferri, F., Narros‐Fernández, P., de Pascual, R., de Diego, A. M. G., Nicke, A., Egea, J., de Diego, A. M. G., & Ríos, C. D. L. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02145 · Cited by 35
The contribution of ion channels to shaping macrophage behaviour
Selezneva, A. I., Gibb, A. J., & Willis, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.970234 · Cited by 32
P2X7 receptor deletion suppresses γ-radiation-induced hyposalivation
Gilman, K. E., Camden, J. M., Klein, R. R., Zhang, Q., Weisman, G. A., & Limesand, K. H. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00192.2018 · Cited by 32
Baroja‐Mazo, A., Compan, V., Martín‐Sánchez, F., Tapia‐Abellán, A., Couillin, I., & Pelegrı́n, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-42298-4 · Cited by 30
Self-citationCrosstalk between purinergic receptors and lipid mediators in leishmaniasis
Chaves, M. M., Canetti, C. D. A., & Coutinho‐Silva, R. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1781-1 · Cited by 28
Modulating ion channel function with antibodies and nanobodies
Stortelers, C., Pinto-Espinoza, C., Hoorick, D. V., & Koch‐Nolte, F. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.02.003 · Cited by 27
Lucas‐Ruiz, F., Agudo‐Barriuso, M., Galindo‐Romero, C., Albaladejo‐García, V., & Vidal‐Sanz, M. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.310670 · Cited by 26
Li, X., Mazaleuskaya, L. L., Ballantyne, L. L., Meng, H., FitzGerald, G. A., & Funk, C. D. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m080028 · Cited by 26
P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption
Jiang, Z., Wu, W. H., Hu, H.-B., Li, Z., Zhong, M., & Zhang, L. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i36.5265 · Cited by 25
Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function
Aprile-Garcia, F., Metzger, M. W., Páez-Pereda, M., Stadler, H., Acuña, M., Liberman, A. C., Senin, S. A., Gerez, J., Hoijman, E., Refojo, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151862 · Cited by 27
Fliegert, R., Heeren, J., Koch‐Nolte, F., Nikolaev, V. O., Lohr, C., Meier, C., & Guse, A. H. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180419 · Cited by 25
Purinergic receptors and the inflammatory response mediated by lipids
Alarcón‐Vila, C., Pizzuto, M., & Pelegrı́n, P. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.004 · Cited by 25
Self-citationEndo, Y., Blinova, K., Romantseva, T., Golding, H., & Zaitseva, M. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098517 · Cited by 25
Manfredini, M., Giuliani, A. L., Ruina, G., Gafà, R., Bosi, C., Zoppas, E., Virgilio, F. D., & Bettoli, V. (2019) · Dermatology · doi:10.1159/000502026 · Cited by 25
Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer
Mohammed, A., Janakiram, N. B., Madka, V., Pathuri, G., Li, Q., Ritchie, R. L., Biddick, L., Kutche, H., Zhang, Y., Singh, A. K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22085 · Cited by 24
Boeno, C. N., Paloschi, M. V., Lopes, J. A., Souza Silva, M. D., Evangelista, J. R., dos Reis, V. P., da S. Setúbal, S., Soares, A. M., & Zuliani, J. P. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109194 · Cited by 24
Través, P. G., Pimentel-Santillana, M., Carrasquero, L. M. G., Pérez‐Sen, R., Delicado, E. G., Luque, A., Izquierdo, M., Martín‐Sanz, P., Miras‐Portugal, M. T., & Boscá, L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203029 · Cited by 24
Impact of FDA-Approved Drugs on the Prostaglandin Transporter OATP2A1/SLCO2A1
Kamo, S., Nakanishi, T., Aotani, R., Nakamura, Y., Gose, T., & Tamai, I. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.046 · Cited by 23
Dai, X., Fang, X., Xia, Y., Li, M., Li, X., Wang, Y., Tao, J., & Li, X.-P. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s351660 · Cited by 22
P2X7 receptor activation impairs antitumour activity of natural killer cells
Baroja‐Mazo, A., Peñín‐Franch, A., Lucas‐Ruiz, F., de Torre‐Minguela, C., Alarcón‐Vila, C., Hernández‐Caselles, T., & Pelegrı́n, P. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15951 · Cited by 22
Self-citationR270C polymorphism leads to loss of function of the canine P2X7 receptor
Spildrejorde, M., Bartlett, R., Stokes, L., Jalilian, I., Peranec, M., Sluyter, V., Curtis, B. L., Skarratt, K. K., Skora, A. S., Bakhsh, T., et al. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00195.2013 · Cited by 22
P2X7 receptor in skin biology and diseases
Geraghty, N. J., Watson, D., Adhikary, S. R., & Sluyter, R. (2016) · World Journal of Dermatology · doi:10.5314/wjd.v5.i2.72 · Cited by 21
Xu, X., Pocock, G. M., Sharma, A., Peery, S. L., Fites, J. S., Felley, L. E., Żarnowski, R., Stewart, D., Berthier, E., Klein, B. S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.061 · Cited by 21
Regulation of ATP-Gated P2X Channels: From Redox Signaling to Interactions with Other Proteins
Stojilković, S. S., Leiva‐Salcedo, E., Rokic, M. B., & Coddou, C. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5549 · Cited by 23
Mittal, R., Chan, B., Grati, M., Mittal, J., Patel, K., Debs, L. H., Patel, A. P., Yan, D. L. S., Chapagain, P. P., & Liu, X. Z. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25274 · Cited by 21
Isolation of functional mature peritoneal macrophages from healthy humans
Ruiz‐Alcaraz, A. J., Martínez‐Banaclocha, H., Marín‐Sánchez, P., Carmona‐Martínez, V., Iniesta‐Albadalejo, M. A., Tristán‐Manzano, M., Tapia‐Abellán, A., García–Peñarrubia, P., Machado‐Linde, F., Pelegrı́n, P., et al. (2019) · Immunology and Cell Biology · doi:10.1111/imcb.12305 · Cited by 20
Self-citationXie, F., Xu, L., Zhu, H., Chen, Y., Li, Y., Nong, L., Zeng, Y., & Cen, S. (2022) · Molecules · doi:10.3390/molecules27082465 · Cited by 19
Zou, Y.-T., Li, J., Chai, J.-Y., Hu, Y., Zhang, W., & Zhang, Q. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149513 · Cited by 20
Davis, C. J., Taishi, P., Honn, K. A., Koberstein, J. N., & Krueger, J. M. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00167.2016 · Cited by 19
Meyer, L., Leymarie, O., Chevalier, C., Esnault, E., Moroldo, M., da Costa, B. R., Georgeault, S., Roingeard, P., Delmas, B., Quéré, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176355 · Cited by 18
Metadata
- Authors
- Barberà‐Cremades, M., Baroja‐Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., & Pelegrín, P.
- Affiliations
- Inflammation and Experimental Surgery Unit Centro de Investigación Biomédica en Red de Enfermedades Hepaticas y Digestivas (CIBERhed)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- Hospital Universitario Virgen de la Arrixaca (ES)
- Section of General Pathology, Department of Experimental and Diagnostic Medicine University of Ferrara Ferrara Italy
- ORCID
- Baroja‐Mazo, Alberto
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2012-04-06
- Volume
- 26
- Issue
- 7
- Pages
- 2951-2962
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2147692999
- Cited by
- 142
- References
- 62
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 11 · 2020: 5 · 2019: 18 · 2018: 4 · 2017: 16 · 2016: 13 · 2015: 12 · 2014: 17 · 2013: 11 · 2012: 3
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Hispana (publishedVersion, cc-by-nc-nd)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- P2X7 receptor, fever, prostaglandin E2, IL-1β, extracellular ATP, inflammasome, lipopolysaccharide, endogenous pyrogen, P2X7 receptor antagonists, acute inflammation, inflammatory pain, autacoids
- MeSH terms
- Adenosine Triphosphate, Animals, Fever, Humans, Injections, Intraperitoneal, Leukotriene B4, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Recombinant Proteins, Thromboxane B2, Dinoprostone, Mice, Knockout, Inflammation Mediators, Calcium Signaling, MAP Kinase Signaling System, Mice, Cyclooxygenase 2, Interleukin-1beta, Receptors, Purinergic P2X7, Receptors, Purinergic P2X4, Purinergic P2X Receptor Agonists, Purinergic P2X Receptor Antagonists, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review